AAOS News: Stryker Rolls Out Mako Total Knee 2.0

Stryker announced the launch of its Mako Total Knee 2.0, the next-gen device in its Mako SmartRobotics portfolio, at the AAOS 2023 annual meeting in Las Vegas.
 
Mako Total Knee 2.0 includes a new design, customizable workflow, and digital tensioner that helps assess knee stability intraoperatively during a total knee arthroplasty (TKA) without needing further instrumentation.
 
The new knee is built on Mako SmartRobotics’ legacy and its three components: 3D CT-based planning, AccuStop haptic technology, and Insightful Data Analytics.
 
“Mako Total Knee 2.0 combines our cutting edge Mako Technology with our clinically proven Triathlon implants to help surgeons deliver enhanced patient outcomes,” Don Payerle, president of Stryker’s Joint Replacement division told the press. “Over the last six years, we’ve gathered key feedback from our customers and incorporated those findings into the development of Mako Total Knee 2.0—reflecting our ongoing commitment to our customers and their patients.” 
 
Mako systems are currently installed across 35 countries and over one million Mako surgeries have been performed worldwide.
 
“Stryker’s recent 1 million procedure milestone is an unprecedented achievement in orthopaedic robotics and a testament to the overwhelming global adoption and patient impact of Mako SmartRobotics,” said Payerle. “We look forward to continuing to help so many patients get back to the activities they love.” 
 
Mako Total Knee 2.0 has over 3,000 cases to date and began limited release in August 2022. It will continue to roll out in a phased strategy in 2023, beginning in the U.S. and following with launch in select global markets.